Juvenile systemic lupus erythematosus in Bahrain. A tertiary referral center experience

Zakiya Al-Mosawi1, Badriya E Al-Hermi, Khulood K Al-Saad

  • 1Department of Pediatrics, Salmaniya Medical Complex, PO Box 12, Manama, Kingdom of Bahrain. zakee08@hotmail.co.uk

Insights

This study analyzed pediatric systemic lupus erythematosus (SLE) in Bahrain, finding skin and kidney involvement common. Nephritis was a key factor in morbidity and mortality, with a notable coexistence of SLE and sickle cell anemia.

Area of Science:

  • Pediatric Rheumatology
  • Immunology
  • Clinical Medicine

Background:

  • Systemic lupus erythematosus (SLE) is a complex autoimmune disease affecting multiple organ systems.
  • Understanding the specific clinical and serological profiles of pediatric SLE in diverse populations is crucial for effective management.

Purpose of the Study:

  • To analyze the clinical and serological features of pediatric SLE patients in Bahrain.
  • To assess comorbidity, morbidity, and mortality associated with pediatric SLE in this region.

Main Methods:

  • Retrospective review of medical charts of pediatric SLE patients treated at Salmaniya Medical Complex, Bahrain (1998-2007).
  • Data collection included demographics, clinical manifestations, serological markers, comorbidities, and outcomes.

Main Results:

  • Thirty-two pediatric SLE cases were identified, predominantly Bahraini (96.8%).
  • Commonly affected systems included skin (93%), kidney (81%), and musculoskeletal (65%).
  • High rates of positive antinuclear antibody (90.6%) and anti-dsDNA (65%) were observed. Nephritis was the leading cause of morbidity (21%) and mortality (12.5%). Eight patients (25%) had sickle cell anemia.

Conclusions:

  • Clinical and serological findings in Bahraini pediatric SLE patients align with international data.
  • Nephritis is a significant driver of morbidity and mortality in this cohort.
  • The coexistence of SLE and sickle cell anemia warrants further investigation, potentially including genetic studies.
Abstract

Related Concept Videos

Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...